Kinetics on Cells - Bridging the Gap Between Biosensors and Cell-Based Assays

Dokument -

Kinetics on Cells - Bridging the Gap Between Biosensors and Cell-Based Assays

Two experiments with two distinct purposes were performed on the Attana Cell 200. The first experiment intended to find a diagnostic tool to test tumors after surgery to see if they are metastatic. The second experiment tested a herceptin conjugate designed for targeted immunotherapy. Both results showed that the Attana Cell 200 may help lowering clinical stage failure rates.
  • Licens: Medieanvändning
    Innehållet får laddas ner, användas och delas i olika mediekanaler av t.ex. journalister, bloggare, krönikörer, opinionsbildare etc., i syftet att förmedla, redogöra för och kommentera ert pressmeddelande, inlägg eller information, så länge innehållet används oförändrat och i dess helhet. Upphovsmannen ska anges i den omfattning och på det sätt god sed kräver (vilket bl.a. innebär att fotografer till bilder nästan alltid måste anges).
  • Filformat: .pdf
Ladda ner

Ämnen

  • Medicinsk forskning

Kategorier

  • biosensors
  • cells
  • quartz crystal microbalance
  • kinetics

Relaterat innehåll

Tecan and Attana extend distribution agreement

Stockholm, Sweden, October 11, 2011- Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.

The combination between biochemical and cell based assay- Attana appears in International Trade News

Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterize molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out.

En ny Generation av Cell-Biosensorer för cancer-forskning

Läs artikeln i det senaste numret av  IPT (Innovations in Pharmaceutical technologies) om nya generationens cell-biosensorer som möjliggör studier  av molekylära interaktioner direkt på celler och på så sätt indikerar rätt läkemedelskandidater i ett tidigare skede inför bland annat cancer-forskning. Att få fram en bra biologiskt anpassad modell som denna med hjälp av en cell-biosensor minskar kost

A New Generation of Cell-Biosensors targeting Cancer

Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation